resistance, page-18

MW03 & Terry,
"I hope that we will be able to shift some Relenza manufacture to China to make our products more accessible in the country," said Chief Executive Andrew Witty.
The drug, which received the State Food and Drug Administration (SFDA) approval in September for DOMESTIC SALES, is used to fight the flu virus along with Roche's Tamiflu.

If you read all the articles/news, the approval is for the sales of imported Relenza. And we are not dwelling on 2006. Simcere statement is in 2009.

Andrew Witty is a very clever man. Peter Cook in the AGM told shareholders not to be alarmed for Relenza to drop out of the mainstream news because GSK is concentrating on marketing to government specialist. In the same paragraph, Peter Cook told shareholders goverment orders exceed production capacity. When government orders exceed production capacity why is there a need to market Relenza to the governments?

If you need reference for the above information read the CEO's AGM message.